Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30


[Ichthyosis uteri (psoriasis uteri) : A very rare disorder].

von Laffert M, Elezkurtaj S, Sehouli J, Barinoff J, Boschetti Grützmacher E, Arsenic R, Bläker H.

Pathologe. 2018 Jan 8. doi: 10.1007/s00292-017-0403-9. [Epub ahead of print] German.


Vulvar cancer in Germany: increase in incidence and change in tumour biological characteristics from 1974 to 2013.

Holleczek B, Sehouli J, Barinoff J.

Acta Oncol. 2018 Mar;57(3):324-330. doi: 10.1080/0284186X.2017.1360513. Epub 2017 Aug 11.


Primary metastatic breast cancer in the era of targeted therapy - Prognostic impact and the role of breast tumour surgery.

Barinoff J, Schmidt M, Schneeweiss A, Schoenegg W, Thill M, Keitel S, Lattrich CR, Hinke A, Kutscheidt A, Jackisch C.

Eur J Cancer. 2017 Sep;83:116-124. doi: 10.1016/j.ejca.2017.06.002. Epub 2017 Jul 20.


A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.

Harbeck N, Saupe S, Jäger E, Schmidt M, Kreienberg R, Müller L, Otremba BJ, Waldenmaier D, Dorn J, Warm M, Scholz M, Untch M, de Wit M, Barinoff J, Lück HJ, Harter P, Augustin D, Harnett P, Beckmann MW, Al-Batran SE; PELICAN Investigators.

Breast Cancer Res Treat. 2017 Jan;161(1):63-72. doi: 10.1007/s10549-016-4033-3. Epub 2016 Oct 31.


Diagnosis, Therapy and Follow-up Care of Vulvar Cancer and its Precursors. Guideline of the DGGG and DKG (S2k-Level, AWMF Registry Number 015/059, November 2015.

Schnürch HG, Ackermann S, Alt CD, Barinoff J, Böing C, Dannecker C, Gieseking F, Günthert A, Hantschmann P, Horn LC, Kürzl R, Mallmann P, Marnitz S, Mehlhorn G, Hack CC, Koch MC, Torsten U, Weikel W, Wölber L, Hampl M.

Geburtshilfe Frauenheilkd. 2016 Oct;76(10):1035-1049.


Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer.

Michiels S, Pugliano L, Marguet S, Grun D, Barinoff J, Cameron D, Cobleigh M, Di Leo A, Johnston S, Gasparini G, Kaufman B, Marty M, Nekljudova V, Paluch-Shimon S, Penault-Llorca F, Slamon D, Vogel C, von Minckwitz G, Buyse M, Piccart M.

Ann Oncol. 2016 Jun;27(6):1029-34. doi: 10.1093/annonc/mdw132. Epub 2016 Mar 8.


Prognostic Factors for Local, Loco-regional and Systemic Recurrence in Early-stage Breast Cancer.

Kümmel A, Kümmel S, Barinoff J, Heitz F, Holtschmidt J, Weikel W, Lorenz-Salehi F, du Bois A, Harter P, Traut A, Blohmer JU, Ataseven B.

Geburtshilfe Frauenheilkd. 2015 Jul;75(7):710-718.


Intraoperative assessment of margins in breast conservative surgery--still in use?

Thill M, Baumann K, Barinoff J.

J Surg Oncol. 2014 Jul;110(1):15-20. doi: 10.1002/jso.23634. Epub 2014 May 24. Review.


Chemotherapy for 70-Year-Old Women with Breast Cancer in Germany: A Survey by the German Breast Group.

Barinoff J, Traut A, Bauerschlag D, Bischoff J, Herr D, Lübbe K, Lück HJ, Maass N, Mundhenke C, Schmidt M, Schwedler K, Thill M, Steffen J, Loibl S, von Minckwitz G.

Geburtshilfe Frauenheilkd. 2013 May;73(5):433-439.


Everolimus as treatment for breast cancer patients with bone metastases only: results of the phase II RADAR study.

Maass N, Harbeck N, Mundhenke C, Lerchenmüller C, Barinoff J, Lück HJ, Ettl J, Aktas B, Kümmel S, Rösel S, Wagner S, Müller L, Bischoff J, Lübbe K, Schwedler K, Schmidt M, Bauerschlag D, Nekljudova V, von Minckwitz G, Loibl S; German Breast Group.

J Cancer Res Clin Oncol. 2013 Dec;139(12):2047-56. doi: 10.1007/s00432-013-1518-x. Epub 2013 Sep 27.


Outcome of early breast cancer treated in an urban and a rural breast cancer unit in Germany.

Heitz F, Bender A, Barinoff J, Lorenz-Salehi F, Fisseler-Eckhoff A, Traut A, Hils R, Harter P, Kullmer U, du Bois A.

Onkologie. 2013;36(9):477-82. doi: 10.1159/000354624. Epub 2013 Aug 19.


German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.

von Minckwitz G, Möbus V, Schneeweiss A, Huober J, Thomssen C, Untch M, Jackisch C, Diel IJ, Elling D, Conrad B, Kreienberg R, Müller V, Lück HJ, Bauerfeind I, Clemens M, Schmidt M, Noeding S, Forstbauer H, Barinoff J, Belau A, Nekljudova V, Harbeck N, Loibl S.

J Clin Oncol. 2013 Oct 1;31(28):3531-9. doi: 10.1200/JCO.2012.47.2167. Epub 2013 Aug 26.


Ki67 levels as predictive and prognostic parameters in pretherapeutic breast cancer core biopsies: a translational investigation in the neoadjuvant GeparTrio trial.

Denkert C, Loibl S, Müller BM, Eidtmann H, Schmitt WD, Eiermann W, Gerber B, Tesch H, Hilfrich J, Huober J, Fehm T, Barinoff J, Jackisch C, Prinzler J, Rüdiger T, Erbstösser E, Blohmer JU, Budczies J, Mehta KM, von Minckwitz G.

Ann Oncol. 2013 Nov;24(11):2786-93. doi: 10.1093/annonc/mdt350. Epub 2013 Aug 22.


Ki67 measured after neoadjuvant chemotherapy for primary breast cancer.

von Minckwitz G, Schmitt WD, Loibl S, Müller BM, Blohmer JU, Sinn BV, Eidtmann H, Eiermann W, Gerber B, Tesch H, Hilfrich J, Huober J, Fehm T, Barinoff J, Rüdiger T, Erbstoesser E, Fasching PA, Karn T, Müller V, Jackisch C, Denkert C.

Clin Cancer Res. 2013 Aug 15;19(16):4521-31. doi: 10.1158/1078-0432.CCR-12-3628. Epub 2013 Jun 27.


Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordance.

Heitz F, Barinoff J, du Bois O, Hils R, Fisseler-Eckhoff A, Harter P, Heitz J, Willenbrock K, Traut A, du Bois A.

Oncology. 2013;84(6):319-25. doi: 10.1159/000346184. Epub 2013 Apr 19.


Diarrhea associated with afatinib: an oral ErbB family blocker.

Yang JC, Reguart N, Barinoff J, Köhler J, Uttenreuther-Fischer M, Stammberger U, O'Brien D, Wolf J, Cohen EE.

Expert Rev Anticancer Ther. 2013 Jun;13(6):729-36. doi: 10.1586/era.13.31. Epub 2013 Mar 18. Review.


Bevacizumab in the treatment of ovarian cancer.

Heitz F, Harter P, Barinoff J, Beutel B, Kannisto P, Grabowski JP, Heitz J, Kurzeder C, du Bois A.

Adv Ther. 2012 Sep;29(9):723-35. doi: 10.1007/s12325-012-0041-9. Epub 2012 Aug 21. Review.


Clinicopathological differences between breast cancer in patients with primary metastatic disease and those without: a multicentre study.

Barinoff J, Hils R, Bender A, Groß J, Kurz C, Tauchert S, Mann E, Schwidde I, Ipsen B, Sawitzki K, Heitz F, Harter P, Traut A, du Bois A.

Eur J Cancer. 2013 Jan;49(2):305-11. doi: 10.1016/j.ejca.2012.07.027. Epub 2012 Aug 30.


Outcome of immediate re-operation or interval debulking after chemotherapy at a gynecologic oncology center after initially incomplete cytoreduction of advanced ovarian cancer.

Grabowski JP, Harter P, Hils R, Lorenz D, Kaub C, Barinoff J, Heitz F, Traut A, du Bois A.

Gynecol Oncol. 2012 Jul;126(1):54-7. doi: 10.1016/j.ygyno.2012.03.044. Epub 2012 Apr 1.


Requirements to assess feasibility of phase 0 trials during major abdominal surgery: variability of PARP activity.

Heitz F, du Bois A, Rochon J, Scheil-Bertram S, Hils R, Fisseler-Eckhoff A, Barinoff J, Kaub C, Harter P.

Clin Cancer Res. 2012 May 1;18(9):2632-7. doi: 10.1158/1078-0432.CCR-12-0021. Epub 2012 Mar 15.


Re-Challenging Taxanes in Recurrent Breast Cancer in Patients Treated with (Neo-)Adjuvant Taxane-Based Therapy.

Guo X, Loibl S, Untch M, Möbus V, Schwedler K, Fasching PA, Barinoff J, Holms F, Thomssen C, Zahm DM, Kreienberg R, Hauschild M, Eidtmann H, Tauchert S, Mehta K, von Minckwitz G.

Breast Care (Basel). 2011;6(4):279-283. Epub 2011 Aug 19.


Surgery for recurrent ovarian cancer.

Heitz F, du Bois A, Kurzeder C, Pfisterer J, Barinoff J, Grabowski J, Hilpert F, Mahner S, Harter P.

Womens Health (Lond). 2011 Sep;7(5):529-35. doi: 10.2217/whe.11.52. Review.


Prognostic significance of the angiogenic factors angiogenin, endoglin and endostatin in cervical cancer.

Landt S, Mordelt K, Schwidde I, Barinoff J, Korlach S, Stöblen F, Lichtenegger W, Sehouli J, Kümmel S.

Anticancer Res. 2011 Aug;31(8):2651-5.


The utility of an in vitro angiogenesis score for prognosis assessment in patients with cervical cancer.

Landt S, Heidecke H, Reuter C, Korlach S, Blohmer JU, Lichtenegger W, Heusner T, Stöblen F, Thill M, Barinoff J, Sehouli J, Kümmel S.

Anticancer Res. 2011 Aug;31(8):2645-9.


In vitro vascular tube formation testing as a tool for treatment individualisation in patients with cervical cancer.

Landt S, Heidecke H, Korlach S, Reuter C, Schwidde I, Barinoff J, Thill M, Sehouli J, Kümmel S.

Anticancer Res. 2011 Aug;31(8):2609-15.


Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer.

von Minckwitz G, Schwedler K, Schmidt M, Barinoff J, Mundhenke C, Cufer T, Maartense E, de Jongh FE, Baumann KH, Bischoff J, Harbeck N, Lück HJ, Maass N, Zielinski C, Andersson M, Stein RC, Nekljudova V, Loibl S; GBG 26/BIG 03-05 study group and participating investigators.

Eur J Cancer. 2011 Oct;47(15):2273-81. doi: 10.1016/j.ejca.2011.06.021. Epub 2011 Jul 7.


Cerebral metastases in metastatic breast cancer: disease-specific risk factors and survival.

Heitz F, Rochon J, Harter P, Lueck HJ, Fisseler-Eckhoff A, Barinoff J, Traut A, Lorenz-Salehi F, du Bois A.

Ann Oncol. 2011 Jul;22(7):1571-81. doi: 10.1093/annonc/mdq625. Epub 2010 Nov 8.


Monitoring serum HER2 levels during neoadjuvant trastuzumab treatment within the GeparQuattro trial.

Witzel I, Loibl S, von Minckwitz G, Mundhenke C, Huober J, Hanusch C, Henschen S, Hauschild M, Lantzsch T, Tesch H, Latos K, Just M, Hilfrich J, Barinoff J, Eulenburg CZ, Roller M, Untch M, Müller V.

Breast Cancer Res Treat. 2010 Sep;123(2):437-45. doi: 10.1007/s10549-010-1030-9. Epub 2010 Jul 10.


Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complications.

Heitz F, Ognjenovic D, Harter P, Kommoss S, Ewald-Riegler N, Haberstroh M, Gomez R, Barinoff J, Traut A, du Bois A.

Int J Gynecol Cancer. 2010 Jan;20(1):41-6. doi: 10.1111/IGC.0b013e3181c443ba.


Prognostic impact of additional extended surgical procedures in advanced-stage primary ovarian cancer.

Kommoss S, Rochon J, Harter P, Heitz F, Grabowski JP, Ewald-Riegler N, Haberstroh M, Neunhoeffer T, Barinoff J, Gomez R, Traut A, du Bois A.

Ann Surg Oncol. 2010 Jan;17(1):279-86. doi: 10.1245/s10434-009-0787-8. Epub 2009 Nov 7.


Supplemental Content

Loading ...
Support Center